StemCONN 2007

UConn Plays Critical Role In International Conference

StemCONN 2007, an international symposium on stem cell research, will be held in Hartford on March 27 and March 28, 2007. An intensive two-day exploration of adult and embryonic stem cell research and of the potential for development of exciting new therapies, it is expected to attract prominent scientists, academics and leaders in other fields.

StemCONN 2007 was founded by the Connecticut Department of Public Health, the Connecticut Stem Cell Coalition, and Connecticut United for Research Excellence (CURE), the state bioscience organization, in collaboration with the University of Connecticut, Wesleyan University and Yale University, as well as the Juvenile Diabetes Research Foundation and the Connecticut Academy of Science and Engineering.

 

UConn Participants Include:

Marc Lalande, Ph.D.
Professor and Chairman, Department of Genetics and Developmental Biology
University of Connecticut Health Center

David Rowe, M.D.
Professor of Genetics and Developmental Biology
University of Connecticut Health Center

 

StemCONN Website

Ren-He Xu, M.D., Ph.D.
Associate Professor of Genetics and Developmental Biology
Director, Human Embryonic Stem Cell Facility
University of Connecticut Health Center

Xiangzhong (Jerry) Yang, Ph.D.
Professor and Director of Center for Regenerative Biology
University of Connecticut School of Animal Science
Member of the Connecticut Stem Cell Research Advisory Committee

 

The symposium will include:
  • Scientific presentations by leading authorities.
  • A televised public forum.
  • A workshop for ESCRO committees.
  • A panel discussion on commercialization and economic development.
  • A poster session and networking.
  • A briefing for legislators and the news media.

 

Open to the public, StemCONN will offer programs that look at stem cell research from a wide range of perspectives, with components of specific interest to:
  • Scientists, academics and students working in stem cell research.
  • Commercial officers interested in short- and long-term commercialization and economic development opportunities.
  • Members of bioethical review committees, including ESCRO committees and institutional review boards.
  • Connecticut legislators and legislative aides.
  • Patient groups interested in learning more about stem cell research.
  • State officials from around the nation.